Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 564 US-listed equities across 10 industries; the sector accounts for 9.2% of tracked equity market cap and 8.7% of daily volume.
Market cap
$7.68T
-0.62%
-$48.276B · 1D
Sector weight
9.2%
of tracked market cap
Volume 24h
$4.144B
8.7% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
49.7×
Market 30.7×
Dividend yield
1.8%
Market 1.3%
Employees
4.4M
Across 564 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
391.5
Mega caps
7
Median cap
$1.391B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 49.7× · market 20.1×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.2× · market 13×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.8% · market 2.3%
Trading at a 62% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | -0.62% | +0.68% | -1.30% |
| 1 week | -2.52% | +2.19% | -4.71% |
| 1 month | -0.66% | +1.59% | -2.25% |
| 3 months | +1.77% | +2.67% | -0.90% |
| Year to date | +8.62% | +13.38% | -4.76% |
| 1 year | +17.08% | +14.33% | +2.75% |
Constituents
564 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.032T | 13.4% | $1.16K | +1.24% | -2.32% | +2.97% | $112.48M | 38.6× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $613.653B | 8% | $254.82 | +0.75% | -6.30% | -5.31% | $65.06M | 29.2× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $471.383B | 6.1% | $266.76 | +0.38% | +0.18% | +7.23% | $46.32M | 75.2× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $350.548B | 4.6% | $141.94 | +1.72% | -4.54% | -4.39% | $56.56M | 39.2× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $340.416B | 4.4% | $376.15 | -0.64% | -0.44% | -6.16% | $86.07M | 24.1× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $244.048B | 3.2% | $656.71 | -2.96% | -3.23% | +8.90% | $113.75M | 35.6× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $217.705B | 2.8% | $402.71 | -0.07% | -3.69% | +2.43% | $36.43M | 24.9× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $179.02B | 2.3% | $144.26 | -0.26% | -5.22% | -1.62% | $21.8M | -55.3× |
Abbott Laboratories ABT · US | Medical Devices | $170.994B | 2.2% | $98.17 | -1.93% | -2.78% | -6.97% | $35.82M | 27.3× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $156.609B | 2% | $27.48 | +0.26% | -4.32% | -1.12% | $35.97M | 20.9× |
Danaher Corp. DHR · US | Diagnostics & Research | $151.559B | 2% | $215.62 | -2.53% | -5.15% | +5.06% | $57.94M | 37.9× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $143.28B | 1.9% | $404.86 | -0.40% | -2.39% | +15.62% | $21.89M | 45.7× |
| Biotechnology | $127.272B | 1.7% | $502.36 | -0.23% | -4.80% | -5.02% | $18.83M | 28.9× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $121.647B | 1.6% | $59.58 | +1.31% | -6.73% | -7.90% | $31.33M | 13.1× |
Medtronic plc MDT · US | Medical Devices | $111.479B | 1.5% | $87.09 | -1.00% | -2.69% | -5.74% | $221.48M | 21.3× |
McKesson Corporation MCK · US | Medical Distribution | $110.646B | 1.4% | $922.05 | +0.72% | +7.68% | +3.70% | $33.03M | 23.2× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $110.445B | 1.4% | $86.42 | -0.68% | -1.63% | -10.04% | $63.98M | 22.6× |
Stryker Corp. SYK · US | Medical Devices | $106.785B | 1.4% | $278.40 | -2.39% | +1.12% | +0.71% | $58.15M | 28.6× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $94.188B | 1.2% | $432.13 | -0.64% | -0.11% | +7.49% | $20.34M | 13.8× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $86.954B | 1.1% | $400.03 | +1.40% | +1.38% | -0.48% | $11.54M | 16.6× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $77.58B | 1% | $738.74 | +1.69% | -1.80% | -8.83% | $18.03M | 17.5× |
Moderna Inc. MRNA · US | Biotechnology | $74.797B | 1% | $187.46 | -7.75% | -4.98% | +33.59% | $99.45M | -23.7× |
The Cigna Group CI · US | Healthcare Plans | $72.339B | 0.9% | $274.40 | +1.15% | +0.95% | -0.52% | $14.03M | 11.3× |
Boston Scientific Corp. BSX · US | Medical Devices | $61.022B | 0.8% | $42.18 | -0.52% | -4.38% | -6.23% | $39.84M | 16.6× |
Cencora Inc. COR · US | Medical Distribution | $60.373B | 0.8% | $316.38 | +0.46% | +4.14% | -2.56% | $18.6M | 23× |